PDS Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.

About PDSB

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. 

CEO
Frank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees
26
Employees26
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2005
Founded2005
Employees
26
Employees26

PDSB Key Statistics

Market cap
137.57M
Market cap137.57M
Price-Earnings ratio
-2.78
Price-Earnings ratio-2.78
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$4.56
High today$4.56
Low today
$3.85
Low today$3.85
Open price
$3.91
Open price$3.91
Volume
854.31K
Volume854.31K
52 Week high
$10.27
52 Week high$10.27
52 Week low
$3.61
52 Week low$3.61

PDSB News

TipRanks 1d
Options Volatility and Implied Earnings Moves Today, March 27, 2024

Today, several major companies are expected to report earnings: Carnival (CCL), Cintas (CTAS), Durect (DRRX), Altimmune (ALT), RH (RH), GlycoMimetics (GLYC), Ch...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.